Rash Associated with Ibrutinib Therapy for Chronic Lymphocytic Leukemia
2017
Ibrutinib is used in the treatment of chronic myeloid leukemia. While patients taking the drug have developed rashes, there are few case reports and studies documenting this adverse effect. We present a case of rash associated with Ibrutinib therapy in a patient with chronic lymphocytic leukemia.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI